TrialThe AAPS journal2014

Lower exposure and faster clearance of bevacizumab in gastric cancer and the impact of patient variables: analysis of individual data from AVAGAST phase III trial.

Kelong Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.